What Researchers Did
Researchers investigated how hyperbaric oxygen therapy combined with alprostadil affected elderly patients with diabetic kidney disease and their blood marker levels.
What They Found
The combination therapy group achieved a 91.53% effective rate, which was significantly higher than the control group's 74.58%. This treatment also lowered markers for kidney damage (UAER, Scr, BUN), blood sugar (HbA1c, FPG, 2h PG), and improved vascular and immune functions, while adjusting specific serum microRNA levels.
What This Means for Canadian Patients
For elderly Canadians with diabetic kidney disease, this study suggests a potential new treatment combination that could improve kidney function and blood sugar control. However, this specific combined therapy is not a standard treatment in Canada and would require further evaluation and research.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This single study's findings would benefit from validation through larger trials across diverse patient populations.